GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $4,093,000 | -16.5% | 94,044 | -16.4% | 0.15% | -2.0% |
Q1 2022 | $4,899,000 | -15.6% | 112,459 | -14.6% | 0.15% | -11.1% |
Q4 2021 | $5,807,000 | +2011.6% | 131,671 | +1712.9% | 0.17% | +905.9% |
Q1 2020 | $275,000 | -8.0% | 7,263 | +13.9% | 0.02% | +21.4% |
Q4 2019 | $299,000 | +218.1% | 6,375 | +184.9% | 0.01% | +180.0% |
Q1 2019 | $94,000 | +10.6% | 2,238 | +0.9% | 0.01% | 0.0% |
Q4 2018 | $85,000 | -5.6% | 2,218 | -1.2% | 0.01% | 0.0% |
Q3 2018 | $90,000 | +246.2% | 2,245 | +333.4% | 0.01% | 0.0% |
Q2 2013 | $26,000 | – | 518 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |